FDA NDC Directory · JSON-LD · Markdown

Otrexup

NDC 54436-015 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namemethotrexate
Labeler / ManufacturerAntares Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA204824
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsMETHOTREXATE (15 mg/.4mL)
Marketing started20131011
Marketing ended20270430
Package count3

External sources

Source: openFDA. Public-domain (CC0).